Converseer
No Result
View All Result
  • Home
  • Politics
  • Jobs
  • Metro
  • Sports
  • Tech
  • Health
  • News
    • Business
    • Education
    • Entertainment
    • Lifestyle
    • Science & Nature
    • Tourism
  • Trends
PRICING
SUBSCRIBE
  • Home
  • Politics
  • Jobs
  • Metro
  • Sports
  • Tech
  • Health
  • News
    • Business
    • Education
    • Entertainment
    • Lifestyle
    • Science & Nature
    • Tourism
  • Trends
No Result
View All Result
Converseer
No Result
View All Result
  • Home
  • Politics
  • Jobs
  • Metro
  • Sports
  • Tech
  • Health
  • News
  • Trends

Home » Health » Chinese scientists discover Parkinson’s functional network mechanism, report 55.5% efficacy in 2 weeks

Chinese scientists discover Parkinson’s functional network mechanism, report 55.5% efficacy in 2 weeks

February 4, 2026
in Health, Science & Nature
Reading Time: 2 mins read
Chinese scientists discover Parkinson’s functional network mechanism, report 55.5% efficacy in 2 weeks

By Our Reporter

BEIJING (CONVERSEER) – According to a Xinhua News Agency report, Professor Liu Hesheng’s team at Changping Laboratory has for the first time revealed the underlying functional network mechanism of Parkinson’s disease.

The relevant findings were published in Nature on 4 February 2026.

The study analysed brain imaging data from over 800 patients and found abnormal functional connections in the “somatic cognitive network” responsible for action planning and autonomic nervous function in the patients’ brains. The pathologically enhanced connections between this network and multiple deep-brain nuclei are key factors leading to symptoms such as motor disorders.

This mechanism explains the working principle of existing treatments (including deep-brain stimulation surgery and drugs), namely, improving symptoms by modulating this abnormal circuit.

Parkinsons disease Chinese scientists discover Parkinson’s functional network mechanism, report 55.5% efficacy in 2 weeks

Based on this discovery, the team developed a precision brain circuit stimulation system to achieve non-invasive localisation and intervention of treatment targets for Parkinson’s disease.

RELATED NEWS

Peter Obi visits Ogoja maternity hospital, donates N10m

Calabar Neuro-Psychiatric Hospital management denies sponsoring thugs against protesters

’People First’ in Action: SA Nursing Dr Coco-Bassey Commends Gov Otu for Extending Years of Service For Health Workers in the State

Gov Otu approves recruitment of 40 additional doctors

According to clinical data, the treatment group that intervened in the newly discovered somatic cognitive targets achieved a 55.5% effectiveness rate after two weeks, significantly higher than the 22.2% effectiveness rate of traditional motor area stimulation. The device has now obtained national medical device registration approval.

This research was jointly conducted by the Changping Laboratory and more than ten institutions, including Peking University, Tsinghua University, and Henan Provincial People’s Hospital. Academician Xie Xiaoliang, director of the Changping Laboratory, stated that as a national strategic scientific and technological force, the laboratory will continue to promote the clinical application and translation of this research.

The paper can be accessed via the link:
https://doi.org/10.1038/s41586-025-10059-1

Tags: China
Next Post
Apple releases iPadOS 26.3 RC (Download link)

Apple releases iPadOS 26.3 RC (Download link)

Apple releases macOS 26.3 RC (Download link)

Apple releases macOS 26.3 RC (Download link)

Topics

  • Latest News
  • Nigeria
  • Africa
  • Europe
  • Asia
  • Americas
  • United States

Social Media

  • WhatsApp
  • Facebook
  • X (Twitter)
  • YouTube
  • LinkedIn

Special Topics

  • Column
  • Bassey Otu
  • Bola Tinubu
  • Special Reports
  • Profile & Biography
  • Opinion
  • Latest News
  • About
  • Advertise
  • Contact
  • Daily Newsletter
  • Privacy Policy
  • Terms Of Use
  • Write For Us

© 2026 Converseer.

No Result
View All Result
  • About
  • Advertise
  • Contact
  • Daily Newsletter
  • Privacy Policy
  • Terms Of Use
  • Write For Us

© 2026 Converseer.